Target Name: GTPBP2
NCBI ID: G54676
Review Report on GTPBP2 Target / Biomarker Content of Review Report on GTPBP2 Target / Biomarker
GTPBP2
Other Name(s): GTP-binding protein 2 (isoform a) | JABELS | GTP binding protein 2 | MGC74725 | GTPB2_HUMAN | GTPBP2 variant 1 | GTP binding protein 2, transcript variant 1 | GTP-binding protein 2

GTPBP2: A Potential Drug Target and Biomarker

Guanosine triphosphate-binding protein 2 (GTPBP2) is a protein that is expressed in various tissues and cells in the human body. It is a key regulator of intracellular signaling, and its function is crucial in the regulation of cell growth, differentiation, and survival. GTPBP2 has also been implicated in the development and progression of various diseases, including cancer. As a result, GTPBP2 has emerged as a promising drug target and biomarker.

GTPBP2 is a protein that is composed of 254 amino acids and has a calculated molecular mass of 31.1 kDa. It is expressed in various tissues and cells, including the brain, heart, skeletal muscles, and liver. GTPBP2 is a G-protein-coupled receptor (GPCR), which means that it is involved in the regulation of intracellular signaling pathways. GTPBP2 functions as a negative regulator of the protein Pyh1, which is a GPCR that is involved in cell survival and proliferation.

GTPBP2 is involved in the regulation of many cellular processes, including cell growth, differentiation, and apoptosis. It has been shown to play a role in the regulation of cell proliferation, differentiation, and survival. For example, GTPBP2 has been shown to inhibit the proliferation of cancer cells, and it has also been shown to enhance the sensitivity of cancer cells to chemotherapy.

GTPBP2 has also been shown to play a role in the regulation of cell apoptosis. Apoptosis is a natural process that is involved in the regulation of cell life cycle, and it is crucial for the development and progression of diseases. GTPBP2 has been shown to regulate the apoptosis of cancer cells, and it has been shown to protect cancer cells from apoptosis.

GTPBP2 has also been implicated in the development and progression of various diseases, including cancer. For example, GTPBP2 has been shown to be overexpressed in various types of cancer, including breast cancer and colon cancer. It has also been shown to be involved in the regulation of cancer cell migration and invasion. As a result, GTPBP2 has emerged as a potential drug target and biomarker for cancer.

In addition to its potential role in cancer, GTPBP2 has also been implicated in the regulation of other cellular processes. For example, GTPBP2 has been shown to regulate the regulation of cell adhesion, which is the process by which cells stick together and form tissues. GTPBP2 has also been shown to regulate the regulation of cell migration, which is the process by which cells move from one location to another.

GTPBP2 has also been shown to play a role in the regulation of neurotransmitter signaling. Neurotransmitters are chemical messengers that are used by the nervous system to communicate with other cells. GTPBP2 has been shown to regulate the function of neurotransmitters, including dopamine and serotonin.

GTPBP2 has also been shown to play a role in the regulation of pain perception. Pain perception is the process by which the body responds to the presence of danger or injury. GTPBP2 has been shown to regulate the function of pain receptors, which are responsible for detecting the presence of danger or injury in the body.

In conclusion, GTPBP2 is a protein that is involved in the regulation of many cellular processes in the human body. It has been shown to play a role in the regulation of cell growth, differentiation, and apoptosis, as well as the regulation of cell adhesion, migration, and neurotransmission. As a result, GTPBP2 has emerged as a promising drug target and biomarker for cancer. Further research is needed to fully understand the role of GTPBP2 in these processes and to develop effective treatments for cancer and other diseases.

Protein Name: GTP Binding Protein 2

The "GTPBP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GTPBP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GTPBP3 | GTPBP4 | GTPBP6 | GTPBP8 | GTSCR1 | GTSE1 | GTSE1-DT | GTSF1 | GTSF1L | Guanine nucleotide-binding protein G(t) complex | Guanylate cyclase | Guanylate kinase (isoform b) | GUCA1A | GUCA1B | GUCA1C | GUCA2A | GUCA2B | GUCD1 | GUCY1A1 | GUCY1A2 | GUCY1B1 | GUCY1B2 | GUCY2C | GUCY2D | GUCY2EP | GUCY2F | GUCY2GP | GUF1 | GUK1 | GULOP | GULP1 | GUSB | GUSBP1 | GUSBP11 | GUSBP12 | GUSBP14 | GUSBP15 | GUSBP17 | GUSBP2 | GUSBP3 | GUSBP4 | GUSBP5 | GUSBP8 | GVINP1 | GVQW3 | GXYLT1 | GXYLT1P3 | GXYLT1P4 | GXYLT1P6 | GXYLT2 | GYG1 | GYG2 | GYPA | GYPB | GYPC | GYPE | GYS1 | GYS2 | GZF1 | GZMA | GZMB | GZMH | GZMK | GZMM | H1-0 | H1-1 | H1-10 | H1-10-AS1 | H1-2 | H1-3 | H1-4 | H1-5 | H1-6 | H1-7 | H1-8 | H1-9P | H19 | H19-ICR | H2AB1 | H2AB2 | H2AB3 | H2AC1 | H2AC11 | H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX